Advocating for Health Equity

Shaping a new era of global health investment, policy, planning and prevention

AVAC Meeting in NYC

Advocacy and activism have been a linchpin in the history of HIV treatment and prevention. The visionary work of passionate advocates has resulted in hard-fought global gains against HIV.

AVAC is part of a robust civil society movement helping to shape a new era of global health spending and planning related to HIV prevention. We mobilize to ensure programs, products and policies are evidence-based, inclusive and effective. With our partner network, we identify critical needs and develop strategic campaigns to advance HIV prevention, with a focus on ensuring a rich pipeline of options move through research and development, and rollout effectively to reach the communities who need them most.

Our advocacy takes place:

  • Where funders, policies and programs come together.
  • At the point of service delivery, where options from the pipeline must become choices in people’s lives. 
  • At Parliaments, State Houses, Ministries of Health, National legislatures, and international bodies,to press for global and country accountability.
  • In the hands of robust and sophisticated coalitions of African-led civil society organizations.

The Latest on Advocating for Health Equity

Event

WHO-Lancet Global Health Series: Shaping the Future of Clinical Trials

WHO and partners, including AVAC, will convene to to launch the Lancet Global health series: Shaping the Future of Clinical Trials. More details to come.

Report

PxWire Volume 15, Issue No. 1

In this special edition of Px Wire, AVAC is going beyond a quarterly update of biomedical HIV prevention. We look at how the new US Administration’s attack on global health can be expected to devastate HIV prevention, including the capacity to deliver existing PrEP options, the scale up of new PrEP products, and the paralyzing impact on research and development.

thumbnail of PxWire March2025 issue